Skip to main content
editorial
. 2021 Oct 25;7(4):00507-2021. doi: 10.1183/23120541.00507-2021

TABLE 1.

Economic burden of bronchiectasis

Outpatient direct costs Inpatient direct costs Advanced disease costs Indirect costs
Medication costs Length of stay Long-term oxygen therapy Work productivity impairment (absenteeism and presenteeism)
Medical appointments Intravenous antibiotics Non-invasive ventilation Disability and early retirement
Physiotherapy ICU resources Lung transplantation Limitations of daily life
Pulmonary rehabilitation Inpatient physiotherapy Caregiver burden
Treatment of exacerbations Imaging and laboratory exams
Treatment of complications Treatment of complications
Sputum microbiology
Radiology
Laboratory exams

ICU: intensive care unit.